TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07413926: Mitral Valve Repair With the Chord-X System: A Long Term Evaluation

Sponsor: Artivion Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 110 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$6,440,800

Rescue Site Savings

+$4,249,600

Unlock Full NCT07413926 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07413926 Rescue Dossier →